HOPE ODOM: Open Payments
NPI 1609411263 · COLLEGE STATION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,030 in 98 payments from 26 companies in 2025. Trend: 2023 $1,885 · 2024 $2,519 · 2025 $2,030
Food & beverage: $2,030
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $421 |
| AstraZeneca Pharmaceuticals LP | 5 | $241 |
| Axsome Therapeutics, Inc. | 10 | $216 |
| ABBVIE INC. | 15 | $206 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $148 |
| Amgen Inc. | 5 | $92 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Antares Pharma, Inc. | 4 | $71 |
| PFIZER INC. | 3 | $69 |
| Corium, LLC | 2 | $59 |
Products named: VRAYLAR, FARXIGA, Sunosi, Ozempic, JARDIANCE, Wegovy, Rybelsus, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
